title: Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.
authors.affiliation: Service de Cardiologie et Laboratoire d'Hemostase, CHU St-Jacques, Besancon, France.
authors.forename: R
authors.initials: R
authors.lastname: Faivre
authors.forename: E
authors.initials: E
authors.lastname: Neuhart
authors.forename: M
authors.initials: M
authors.lastname: Mirshahi
authors.forename: M
authors.initials: M
authors.lastname: Mirshahi
authors.forename: C
authors.initials: C
authors.lastname: Soria
authors.forename: J
authors.initials: J
authors.lastname: Soria
authors.forename: J P
authors.initials: JP
authors.lastname: Bassand
authors.forename: J P
authors.initials: JP
authors.lastname: Caen
authors.forename: J P
authors.initials: JP
authors.lastname: Maurat
mesh_terms: D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D007118:Immunoassay; D010690:Phlebography; D011655:Pulmonary Embolism / Q000145:classification / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin